Issues in Genetics
Policy, legal and ethical issues in genetic research
Share Share
Feature

NHGRI welcomes new education and policy fellows

Read moreElizabeth Tuck, M.A. and Katherine Blizinsky, Ph.D. will begin their fellowships - sponsored by NHGRI and the American Society of Human Genetics - in September 2014.  Ms. Tuck starts her fellowship in the new Genetics and Education Fellowship program, while Dr. Blizinsky starts hers in the Genetics and Public Policy Fellowship program. Read more


We Speak Your Name: Brooklyn community celebrates Henrietta Lacks

Read moreThe world owes much to Henrietta Lacks, the African-American woman whose cells were removed during a biopsy in 1951 and used for research without her knowledge or approval. Mrs. Lacks died at the age of 31, a few months after her diagnosis of cervical cancer. She would never know that more than six decades later, her cells would continue to grow and provide a foundation for advancements in biomedical research. Read more

 
Highlights

FDA proposes oversight of laboratory-developed tests

FDA logo The U.S. Food and Drug Administration (FDA) today announced steps it will take to ensure that certain tests used by health care professionals to diagnose and treat patients provide accurate, consistent and reliable results to inform patient care. These steps come at a critical time for genomic, or precision, medicine. As more and more genetic tests are developed and marketed, the public must be able to rely on the accuracy and clinical validity of these tests.
Read the FDA Release
Read a statement from NIH Director Francis Collins
Workshop Summary

Meeting on the implications of the ACMG Recommendations

Read more

Read the full summary of the workshop to discuss the potential implications on research policies of recommendations and guidelines regarding the management of incidental findings when patients undergo clinical exome or genome sequencing. 
Workshop Summary
PDF file



Last Updated: September 15, 2014